tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

LUCD Stock Latest News

Lucid Diagnostics entered first concierge medicine contract with LEAA Health
The FlyLucid Diagnostics entered first concierge medicine contract with LEAA Health
2d ago
LUCD
PAVM
Lucid Diagnostics reports record quarterly EsoGuard test volume
PremiumThe Fly
Lucid Diagnostics reports record quarterly EsoGuard test volume
1M ago
LUCD
PAVM
Lucid Diagnostics granted 180-day extension by Nasdaq to regain compliance
PremiumThe Fly
Lucid Diagnostics granted 180-day extension by Nasdaq to regain compliance
2M ago
LUCD
Lucid Diagnostics partners for esophageal precancer detection for firefighters
PremiumThe Fly
Lucid Diagnostics partners for esophageal precancer detection for firefighters
2M ago
LUCD
PAVM
Lucid announces publication on EsoGuard in peer-reviewed journal Medicina
PremiumThe Fly
Lucid announces publication on EsoGuard in peer-reviewed journal Medicina
2M ago
LUCD
PAVM
Lucid Diagnostics completes convertible debt refinancing
PremiumThe FlyLucid Diagnostics completes convertible debt refinancing
3M ago
LUCD
PAVM
Lucid Diagnostics’ Strategic Financial Maneuvering and Agreements
Premium
Company Announcements
Lucid Diagnostics’ Strategic Financial Maneuvering and Agreements
3M ago
8K
LUCD
Lucid Diagnostics submits clinical evidence for EsoGuard Esophagea DNA test
Premium
The Fly
Lucid Diagnostics submits clinical evidence for EsoGuard Esophagea DNA test
3M ago
LUCD
PAVM
Lucid Diagnostics Reports Q3 Revenue Growth and Strategic Expansion
PremiumCompany Announcements
Lucid Diagnostics Reports Q3 Revenue Growth and Strategic Expansion
3M ago
LUCD
Lucid Diagnostics Reports Revenue Growth and Secures Funding
PremiumCompany Announcements
Lucid Diagnostics Reports Revenue Growth and Secures Funding
3M ago
8K
LUCD
Lucid Diagnostics reports Q3 adjusted EPS (20c), consensus (22c)
PremiumThe Fly
Lucid Diagnostics reports Q3 adjusted EPS (20c), consensus (22c)
3M ago
LUCD
Lucid Diagnostics Announces Convertible Notes Exchange Initiative
PremiumCompany Announcements
Lucid Diagnostics Announces Convertible Notes Exchange Initiative
3M ago
8K
LUCD
LUCD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsLUCD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
LUCD
Lucid Diagnostics granted patent underlying its EsoGuard Esophageal DNA Ttest
Premium
The Fly
Lucid Diagnostics granted patent underlying its EsoGuard Esophageal DNA Ttest
4M ago
LUCD
PAVM
Castle Biosciences price target raised to $40 from $35 at BTIG
Premium
The Fly
Castle Biosciences price target raised to $40 from $35 at BTIG
4M ago
CSTL
LUCD
Lucid Diagnostics management to meet virtually with BTIG
PremiumThe Fly
Lucid Diagnostics management to meet virtually with BTIG
5M ago
LUCD
PAVmed announces efforts to regain Nasdaq compliance
PremiumThe Fly
PAVmed announces efforts to regain Nasdaq compliance
5M ago
LUCD
PAVM
Lucid Diagnostics partnering with Front Line Mobile Health in esophageal cancer
PremiumThe Fly
Lucid Diagnostics partnering with Front Line Mobile Health in esophageal cancer
6M ago
LUCD
PAVM
Lucid Diagnostics’ EsoGuard cancer diagnosis test highlighted in publication
PremiumThe Fly
Lucid Diagnostics’ EsoGuard cancer diagnosis test highlighted in publication
6M ago
LUCD
PAVM
Lucid Diagnostics Unveils Key Unfiled Financial Snapshot
PremiumCompany AnnouncementsLucid Diagnostics Unveils Key Unfiled Financial Snapshot
6M ago
8K
LUCD
Lucid Diagnostics reports Q2 EPS (20c), consensus (22c)
Premium
The Fly
Lucid Diagnostics reports Q2 EPS (20c), consensus (22c)
6M ago
LUCD
Lucid Diagnostics’ EsoGuard esophageal precancer testing shows efficacy
Premium
The Fly
Lucid Diagnostics’ EsoGuard esophageal precancer testing shows efficacy
7M ago
LUCD
PAVM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >